Consolidated Water, the company that has won the $22 million Blue Hills reverse osmosis plant contract, is facing the possible delisting of its shares from New York’s Nasdaq stock exchange.
The possible suspension relates to the company’s failure to file its Form 10-K for its financial year that ended on December 31, 2004, with the US capital markets regulator, the Securities and Exchange Commission (SEC).
As a result, Consolidated Water, which also owns the Waterfields reverse osmosis facility in New Providence, has received a note from the US stock exchange saying it is not in compliance with Nasdaq Marketplace Rules and its ordinary shares are therefore subject to delisting.
